ScieGen Pharmaceuticals Inc. Unclassified
FDA Approved Drugs

ScieGen Pharmaceuticals Inc. Unclassified

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Unclassified
  • Total Records 6
  • Latest Approval Date -
  • Data Source FDA
  • First Approval Date -
All
266
View
Unclassified
6
View
Discontinued
37
View
OTC
4
View
RX
219
View
Company Overview

Company

ScieGen Pharmaceuticals Inc. Unclassified

Country

U.S.A

Website

Visit Website

Email

info@sciegenpharm.com

Social Profiles

Company Snapshot

ScieGen Pharmaceuticals Inc. Unclassified

20 Davids Driv, Hauppauge, NY 11788

U.S.A

sciegenpharm.com/ info@sciegenpharm.com View on Map
FDA Approved Drug Records ( 6 records )
-
Unclassified Application: 218119

Drug Name

APIXABAN

Product Number

2

Dosage Form

-

Strength

2.5MG

Approval Date

-

218119 / 2

Active Ingredient

APIXABAN

Application Number

218119

Product Number

2

Dosage Form

-

Strength

2.5MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219408

Drug Name

DAPAGLIFLOZIN

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

-

219408 / 1

Active Ingredient

DAPAGLIFLOZIN

Application Number

219408

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 219408

Drug Name

DAPAGLIFLOZIN

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

-

219408 / 2

Active Ingredient

DAPAGLIFLOZIN

Application Number

219408

Product Number

2

Dosage Form

-

Strength

10MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 216337

Drug Name

SITAGLIPTIN

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

-

216337 / 1

Active Ingredient

SITAGLIPTIN

Application Number

216337

Product Number

1

Dosage Form

-

Strength

25MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 216337

Drug Name

SITAGLIPTIN

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

-

216337 / 2

Active Ingredient

SITAGLIPTIN

Application Number

216337

Product Number

2

Dosage Form

-

Strength

50MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 216337

Drug Name

SITAGLIPTIN

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

-

216337 / 3

Active Ingredient

SITAGLIPTIN

Application Number

216337

Product Number

3

Dosage Form

-

Strength

100MG

Approval Date

-

Regulatory Status

Unclassified

Related Databases
  • FDA Inspections
    14 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    266 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
6 total
  • Unclassified
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

APIXABAN

Application Number

218119

Product Number

2

Active Ingredient

APIXABAN

Dosage Form

-

Strength

2.5MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit